62 completed, 5 not yet recruiting, 4 unknown, 3 recruiting. 27 Phase 4, 26 Phase 3, 10 Phase 2, 6 Phase 1, 5 Not applicable.
Follow desloratadine: new trials by email Literature Review of desloratadine trials Research Report on desloratadine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate DEP114 for the Treatment of Acute Exacerbation of Persistent Allergic Rhinitis in Children Aged 6 to Under 12 Years DEP114, Desloratadine - Persistent Allergic Rhinitis | Phase 3 | Not yet recruiting | EMS | 316 | 2027-06-01 | 2026-09-22 |
| Impact of the Antihistamine Desloratadine on the Quality of Life and Dysmenorrhea in Patients With Endometriosis Desloratadine, Placebo - Endometriosis, Endometriosis (Diagnosis) | Phase 2 | Not yet recruiting | Medical University of Vienna | 60 | 2027-02-01 | 2026-09-18 |
| Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer Biospecimen Collection, Cholecalciferol, Computed Tomography - Advanced Hepatocellular Carcinoma, Advanced Melanoma | Phase 2 | Not yet recruiting | University of Southern California | 46 | 2026-11-01 | 2026-09-23 |
| Desloratadine as Adjunct Therapy for Rheumatoid Arthritis Desloratadine 5 mg, Placebo - Rheumatoid Arthritis (RA), Rheumatoid Arthritis | Phase 2 | Recruiting | Horus University | 60 | 2026-05-23 | 2026-06-08 |
| Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients. Autologous whole blood therapy, Desloratadine - Chronic Idiopathic Urticaria | Phase 3 | Not yet recruiting | Cairo University | 40 | 2026-04-30 | 2026-03-20 |
| Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid Arthritis Roflumilast, Desloratadine, Placebo - Rheumatoid Arthritis | Phase 2 | Recruiting | Horus University | 90 | 2026-04-23 | 2026-05-12 |
| Desloratadine in Patients With Ulcerative Colitis Desloratadine, mesalamine - Ulcerative Colitis (UC), Ulcerative Colitis | Phase 2 | Recruiting | Tanta University | 44 | 2026-01-26 | 2026-01-29 |
| Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children. DEP114, Desloratadine 0.5 MG/ML - Allergic Rhinitis | Phase 3 | Not yet recruiting | EMS | 318 | 2025-02-15 | 2024-02-22 |
| Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine Desloratadine / Betamethasone in fixed dose, Desloratadine - Allergic Rhinitis | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 70 | 2024-11-11 | 2026-07-23 |
| Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children Desloratadine , Prednisolone, Desloratadine - Allergic Rhinitis | Phase 3 | Completed | Eurofarma Laboratorios S.A. | 262 | 2024-07-08 | 2026-10-26 |
| Over-the-Counter Antihistamines & Heat Stress 50 mg Diphenhydramine, 10 mg Loratadine, 5 mg Desloratadine - Heat Illness, Allergic Rhinitis | Phase 4 | Unknown | Lakehead University | 16 | 2023-12-05 | 2024-01-22 |
| Role of Desloratadine in Reducing Inflammation From Occupational Heat Strain Desloratadine, Placebo, No Intervention - Heat Stress, Exertional, Inflammatory Response | Not applicable | Unknown | University of Victoria | 12 | 2022-07-01 | 2022-07-06 |
| Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin. Desloratadine Single Dose, Levocetirizine Single Dose, Desloratadine Fourfold Dose - Pruritus | Not applicable | Completed | Universitaire Ziekenhuizen KU Leuven | 12 | 2019-10-28 | 2020-05-27 |
| Influence of Antipruritics on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin. Desloratadine 5 mg, Aprepitant 125 mg, Ketotifen 1 MG - Pruritus | Not applicable | Completed | Universitaire Ziekenhuizen KU Leuven | 13 | 2019-06-11 | 2020-05-27 |
| Antiplatelet Therapy in Chronic Urticaria Desloratadine plus cilostazol and dipyridamole, Desloratadine - Chronic Urticaria | Phase 2 | Unknown | Chulalongkorn University | 12 | 2018-06-01 | 2024-02-21 |
| Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment Aprepitant, Desloratadine, Placebo of aprepitant - Non-small Cell Lung Cancer | Phase 2 | Completed | Sun Yat-sen University | 138 | 2015-12-01 | 2021-05-18 |
| Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204) Desloratadine 5 mg, Placebo - Seasonal Allergic Rhinitis | Phase 3 | Completed | Organon and Co | 449 | 2015-01-09 | 2024-05-17 |
| Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment Desloratadine + Prednisolone, Dexchlorpheniramine + Betamethasone - Cutaneous Hypersensitivity | Phase 3 | Terminated | EMS | 17 | 2014-02-01 | 2017-02-16 |
| Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Persistent Allergic Rhinitis Treatment Dexchlorpheniramine + Betamethasone, Desloratadine + Prednisolone - Allergic Rhinitis | Phase 3 | Completed | EMS | 210 | 2013-11-01 | 2015-01-15 |
| Anti-histamines and Methacholine Challenges. Diphenhydramine, cetirizine, desloratadine - Asthma | Phase 4 | Completed | Don Cockcroft | 12 | 2013-11-01 | 2015-04-08 |
Showing 20 of 77. Sign in to see all of them.
Rhinitis, Allergic, Seasonal (17) · Rhinitis, Allergic (13) · Urticaria (13) · Chronic Urticaria (7) · Hypersensitivity (7) · Rhinitis (7) · Rhinitis, Allergic, Perennial (6) · Asthma (4) · Immune System Diseases (3) · Pruritus (3) · Arthritis, Rheumatoid (2) · Dermatitis, Atopic (2) · Heat Stress Disorders (2) · Hypersensitivity, Immediate (2) · Rhinorrhea (2)
Organon and Co (38) · Dr. Reddy's Laboratories Limited (6) · EMS (5) · ALK-Abelló A/S (2) · Charite University, Berlin, Germany (2) · Horus University (2) · Universitaire Ziekenhuizen KU Leuven (2) · Cairo University (1) · Chulalongkorn University (1) · Don Cockcroft (1) · Eurofarma Laboratorios S.A. (1) · Faes Farma, S.A. (1) · Grupo de Alergología Clínica y Experimental (1) · Hamilton Health Sciences Corporation (1) · Iuliu Hatieganu University of Medicine and Pharmacy (1)
Canada (7) · United States (6) · Germany (5) · Egypt (4) · Belgium (3) · Brazil (3) · Spain (2) · Austria (1) · China (1) · Colombia (1) · France (1) · Italy (1) · Malaysia (1) · Mexico (1) · Romania (1)
Antonio R Pizarro, MD (3) · Antonio R. Pizarro, M.D., (2) · Marcus Maurer, MD (2) · Amira Mashaly (1) · Diana Hanna (1) · Donald W Cockcroft, MD (1) · Donald W Cockcroft, MD, FRCP(C) (1) · Dr.Denis Audet, MD (1) · Jettanong Klaewsongkram, MD (1) · Li Zhang, professor (1)
PMID 15679739, PMID 16014882, PMID 16913264, PMID 16918326, PMID 17085262, PMID 17298105, PMID 17522250, PMID 17535226, PMID 18048820, PMID 18181978, PMID 19132976, PMID 19133920, PMID 19164343, PMID 19302250, PMID 19624554, PMID 19692680, PMID 19788025, PMID 19793151, PMID 20067329, PMID 20493771, PMID 20532044, PMID 20544226, PMID 20559006, PMID 20820812, PMID 21039410, PMID 21630130, PMID 21783417, PMID 22512843, PMID 22850916, PMID 22870909, PMID 22995650, PMID 23053062, PMID 23282979, PMID 23676577, PMID 24517320, PMID 26740893, PMID 26867531, PMID 27326985, PMID 28709817, PMID 36197287
2008 (1), P30CA014089 (1)